
CVS HEALTH Corp statistics
$89.35−0.49%Close 13 Nov 2026 · Market value $113.1B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
CVS HEALTH Corp is valued at $113.1B on its latest close. Its price is 10.3 times its earnings.
| Market value | $113.1B |
|---|
| Enterprise value | $175.0B |
|---|
| Price / earnings | 10.25 |
|---|
| Price / sales | 0.27 |
|---|
| Price / book | 1.41 |
|---|
| EV / EBITDA | 8.94 |
|---|
| EV / sales | 0.42 |
|---|
| Price / free cash flow | 7.27 |
|---|
| Price / free cash flow, own 5-year average | 11.97 |
|---|
| EV / EBIT | 11.52 |
|---|
| EV / free cash flow | 11.15 |
|---|
| Free cash flow yield | 13.8% |
|---|
| Dividend yield | 3.0% |
|---|
Share price
| Latest close | $89.35 |
|---|
| Day's change | −0.5% |
|---|
| 52-week high | $110.68 |
|---|
| 52-week low | $69.51 |
|---|
| From 52-week high | −19.3% |
|---|
| Return · 1 month | −3.3% |
|---|
| Return · 3 months | −4.6% |
|---|
| Return · year to date | +12.6% |
|---|
| Return · 1 year | +11.3% |
|---|
| Beta · 1 year against the S&P 500 | −0.02 |
|---|
| 50-day average | $89.66 |
|---|
| 200-day average | $89.17 |
|---|
| RSI 14 | 50.9 |
|---|
| Average volume · 20 sessions | 11.0M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 1.2% |
|---|
| Net margin | 0.4% |
|---|
| Free cash flow margin | 1.9% |
|---|
| Return on equity | 2.3% |
|---|
| Return on assets | 1.5% |
|---|
| Return on invested capital | 2.2% |
|---|
| Return on invested capital, 5-year average | 4.2% |
|---|
| Return on capital employed | 2.8% |
|---|
| Stock-based compensation / revenue | 0.1% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $8.45B |
|---|
| Total debt | $79.95B |
|---|
| Net debt | $69.35B |
|---|
| Current ratio | 0.84 |
|---|
| Quick ratio | 0.61 |
|---|
| Debt / equity | 1.06 |
|---|
| Net debt / EBITDA | 7.48 |
|---|
| Interest coverage | 1.49 |
|---|
Growth
| Revenue, latest quarter on a year | +5.4% |
|---|
| Revenue, twelve months on a year | +6.7% |
|---|
| EPS, twelve months on a year | +2218% |
|---|
| Revenue, 5-year compound | +8.4% |
|---|
| Revenue, 10-year compound | +10.1% |
|---|
| Net income, 5-year compound | −24.4% |
|---|
| Free cash flow, 5-year compound | −10.3% |
|---|
| EPS, 5-year compound | −23.9% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 1.3B |
|---|
| Shares outstanding, 5-year compound | −0.7% |
|---|
| Net share repurchases | −$394.0M |
|---|
| Dividends per share | $2.66 |
|---|
| Dividend payout | 192% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $408.0M |
|---|
| Effective tax rate | 19.1% |
|---|
CVS in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.